{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-009154","form_type":"8-K","ticker":"BICX","cik":"0001443863","company_name":"BioCorRx Inc.","filed_at":"2023-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.092923+00:00","generated_at":"2026-06-07T11:49:29.961598+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioCorRx raises $200K via note, warrant & inducement shares; note matures Sep 2024","bullets":["Issued $220K principal note (8% OID) for $200K cash; unsecured, matures Sep 8, 2024.","Six monthly amortization payments of $39,600 starting Apr 8, 2024; prepayable without penalty.","Issued 4-year warrant for 200K shares at $2.00/share exercise price.","Issued 24,000 restricted common shares as inducement.","Securities issued in private placement under Section 4(a)(2) to a single accredited investor."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-009154","json":"https://secwatch.observer/filing/0001477932-23-009154.json","markdown":"https://secwatch.observer/filing/0001477932-23-009154.md","text":"https://secwatch.observer/filing/0001477932-23-009154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223009154/0001477932-23-009154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223009154/bicx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T11:49:29.961598+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0ca9bd5091e150ec33130ace8b665337f87d2695","claim":"BioCorRx Inc. entered into Securities Purchase Agreement with an accredited investor valued at $200,000 (effective 2023-12-08).","evidence_excerpt":"On December 8, 2023, BioCorRx Inc., a Nevada corporation (the “Company”), entered into a securities purchase agreement (the “SPA”) with an accredited investor (the “Investor”), whereby the Investor purchased from the Company, for a purchase price of $200,000 (the “Purchase Price”) (i) a promissory note of the Company in the original principal amount of $220,000.00 (the “Note”), (ii) a common stock purchase warrant for 200,000 shares (the “Warrant”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (iii) 24,000 restricted shares of Common Stock (the “Inducement Shares”, and collectively with the Note and Warrant, the “Securities”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223009154/0001477932-23-009154-index.htm","confidence":0.5,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"an accredited investor"},{"label":"Value","value":"$200,000"},{"label":"Effective","value":"2023-12-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}